daunorubicin has been researched along with Fibroma, Shope in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camera, A; Chiurazzi, F; D'Arco, AM; Risitano, AM; Rossi, M; Rotoli, B | 1 |
Krejovic, B; Pendjer, I; Vucicevic, S | 1 |
Bekesi, JG; Holland, JF | 1 |
1 trial(s) available for daunorubicin and Fibroma, Shope
Article | Year |
---|---|
Active immunotherapy in leukemia with neuraminidase-modified leukemic cells.
Topics: Animals; Antigens, Neoplasm; Clinical Trials as Topic; Cytarabine; Daunorubicin; Humans; Hypersensitivity, Delayed; Immunization; Immunotherapy; Leukemia Virus, Murine; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Mice, Inbred DBA; Neuraminidase; Tumor Virus Infections | 1977 |
2 other study(ies) available for daunorubicin and Fibroma, Shope
Article | Year |
---|---|
Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Burkitt Lymphoma; Carrier Proteins; Daunorubicin; Fatal Outcome; Genetic Heterogeneity; Granulocyte Colony-Stimulating Factor; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Intracellular Signaling Peptides and Proteins; Lamivudine; Lenograstim; Liver Failure; Lymphoproliferative Disorders; Male; Mucormycosis; Pleural Effusion; Prednisone; Recombinant Proteins; Signaling Lymphocytic Activation Molecule Associated Protein; Tumor Virus Infections; Vincristine | 2002 |
A comparative study of undifferentiated nasopharyngeal carcinoma treated with radiotherapy or combined treatment with zorubicin-cisplatin and radiotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Daunorubicin; Drug Administration Schedule; Female; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Tumor Virus Infections | 1997 |